Annual SGA
$30.05 M
-$7.31 M-19.57%
December 31, 2023
Summary
- As of February 7, 2025, TSHA annual SGA is $30.05 million, with the most recent change of -$7.31 million (-19.57%) on December 31, 2023.
- During the last 3 years, TSHA annual SGA has risen by +$18.94 million (+170.47%).
- TSHA annual SGA is now -27.29% below its all-time high of $41.32 million, reached on December 31, 2021.
Performance
TSHA SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly SGA
$7.90 M
+$564.00 K+7.69%
September 30, 2024
Summary
- As of February 7, 2025, TSHA quarterly SGA is $7.90 million, with the most recent change of +$564.00 thousand (+7.69%) on September 30, 2024.
- Over the past year, TSHA quarterly SGA has dropped by -$687.00 thousand (-8.00%).
- TSHA quarterly SGA is now -33.07% below its all-time high of $11.81 million, reached on December 31, 2021.
Performance
TSHA Quarterly SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM SGA
-$2.19 B
-$22.77 M-1.05%
September 30, 2024
Summary
- As of February 7, 2025, TSHA TTM SGA is -$2.19 billion, with the most recent change of -$22.77 million (-1.05%) on September 30, 2024.
- Over the past year, TSHA TTM SGA has dropped by -$2.22 billion (-7245.95%).
- TSHA TTM SGA is now -7793.07% below its all-time high of -$27.77 million.
Performance
TSHA TTM SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Selling, General & Administrative Expenses Formula
SGA = Total Operating Expenses - Cost of Goods Sold - Research & Development
TSHA Selling, General & Administrative Expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -19.6% | -8.0% | -7245.9% |
| 3 y3 years | +170.5% | -29.1% | -6251.8% |
| 5 y5 years | - | +6073.4% | -10000.0% |
TSHA Selling, General & Administrative Expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -27.3% | at low | -33.1% | +32.0% | -238.1% | at low |
| 5 y | 5-year | -27.3% | +170.5% | -33.1% | >+9999.0% | -7793.1% | at low |
| alltime | all time | -27.3% | +170.5% | -33.1% | >+9999.0% | -7793.1% | at low |
Taysha Gene Therapies Selling, General & Administrative Expenses History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $7.90 M(+7.7%) | $29.04 M(-2.3%) |
| Jun 2024 | - | $7.34 M(+3.6%) | $29.73 M(+4.8%) |
| Mar 2024 | - | $7.08 M(+5.4%) | $28.38 M(-5.5%) |
| Dec 2023 | $30.05 M(-19.6%) | $6.72 M(-21.8%) | $30.05 M(-2.0%) |
| Sep 2023 | - | $8.59 M(+43.4%) | $30.67 M(-0.3%) |
| Jun 2023 | - | $5.99 M(-31.6%) | $30.76 M(-11.2%) |
| Mar 2023 | - | $8.75 M(+19.2%) | $34.64 M(-7.3%) |
| Dec 2022 | $37.36 M | $7.34 M(-15.5%) | $37.36 M(-10.7%) |
| Sep 2022 | - | $8.68 M(-12.0%) | $41.83 M(-5.6%) |
| Jun 2022 | - | $9.87 M(-14.0%) | $44.30 M(-0.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2022 | - | $11.47 M(-2.9%) | $44.56 M(+7.8%) |
| Dec 2021 | $41.32 M(+272.0%) | $11.81 M(+5.9%) | $41.32 M(+16.0%) |
| Sep 2021 | - | $11.15 M(+10.1%) | $35.63 M(+25.2%) |
| Jun 2021 | - | $10.13 M(+23.0%) | $28.46 M(+47.6%) |
| Mar 2021 | - | $8.24 M(+34.9%) | $19.27 M(+73.5%) |
| Dec 2020 | $11.11 M | - | - |
| Dec 2020 | - | $6.11 M(+53.3%) | $11.11 M(+116.5%) |
| Sep 2020 | - | $3.98 M(+320.3%) | $5.13 M(+347.6%) |
| Jun 2020 | - | $948.00 K(+1254.3%) | $1.15 M(+478.8%) |
| Mar 2020 | - | $70.00 K(-45.3%) | $198.00 K(+54.7%) |
| Dec 2019 | - | $128.00 K | $128.00 K |
FAQ
- What is Taysha Gene Therapies annual SGA?
- What is the all time high annual SGA for Taysha Gene Therapies?
- What is Taysha Gene Therapies annual SGA year-on-year change?
- What is Taysha Gene Therapies quarterly SGA?
- What is the all time high quarterly SGA for Taysha Gene Therapies?
- What is Taysha Gene Therapies quarterly SGA year-on-year change?
- What is Taysha Gene Therapies TTM SGA?
- What is the all time high TTM SGA for Taysha Gene Therapies?
- What is Taysha Gene Therapies TTM SGA year-on-year change?
What is Taysha Gene Therapies annual SGA?
The current annual SGA of TSHA is $30.05 M
What is the all time high annual SGA for Taysha Gene Therapies?
Taysha Gene Therapies all-time high annual SGA is $41.32 M
What is Taysha Gene Therapies annual SGA year-on-year change?
Over the past year, TSHA annual SGA has changed by -$7.31 M (-19.57%)
What is Taysha Gene Therapies quarterly SGA?
The current quarterly SGA of TSHA is $7.90 M
What is the all time high quarterly SGA for Taysha Gene Therapies?
Taysha Gene Therapies all-time high quarterly SGA is $11.81 M
What is Taysha Gene Therapies quarterly SGA year-on-year change?
Over the past year, TSHA quarterly SGA has changed by -$687.00 K (-8.00%)
What is Taysha Gene Therapies TTM SGA?
The current TTM SGA of TSHA is -$2.19 B
What is the all time high TTM SGA for Taysha Gene Therapies?
Taysha Gene Therapies all-time high TTM SGA is -$27.77 M
What is Taysha Gene Therapies TTM SGA year-on-year change?
Over the past year, TSHA TTM SGA has changed by -$2.22 B (-7245.95%)